The Role of IL4R Alpha in Neonatal RSV Immunopathology
IL4R Alpha 在新生儿 RSV 免疫病理学中的作用
基本信息
- 批准号:8701225
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAblationAdoptive TransferAdultAgeAge-YearsAllergicAnimalsAntisense OligonucleotidesApoptosisAsthmaBronchiolitisCell surfaceCellsCessation of lifeChildhoodChildhood AsthmaComplexDataDendritic CellsDevelopmentDiseaseDown-RegulationElderlyEosinophiliaEpidemiologic StudiesEpidemiologyExposure toExtrinsic asthmaFunctional disorderGenetic PolymorphismGoalsHealth Care CostsHumanIL4R geneImmuneImmune responseImmunityInfantInfectionInflammationInterferon ReceptorInterferonsInterleukin-12Interleukin-13Interleukin-4KnowledgeLifeLigandsLinkLungLung diseasesMediatingModelingMorbidity - disease rateMucous body substanceMusMyelogenousNeonatalOvalbuminPathogenesisPhenotypePopulationPredispositionProductionPulmonary PathologyRegulationRespiratory Syncytial Virus InfectionsRespiratory physiologyRespiratory syncytial virusRiskRisk FactorsRoleSignal PathwaySignal TransductionTerminologyTestingTh1 CellsTherapeutic InterventionTimeUp-RegulationVaccinesage relatedairway hyperresponsivenessairway inflammationburden of illnesscytokineimmunopathologyimmunoregulationinfancyinnovationmethacholinemortalitymouse modelneonatenovelpreventprogramsresponse
项目摘要
DESCRIPTION (provided by applicant: Respiratory Syncytial Virus (RSV) is the leading cause of bronchiolitis in infants worldwide with healthcare costs estimated at $365-$585 million per year. Human epidemiological studies have identified age at initial infection as an independent risk factor for the development of childhood asthma. We have previously demonstrated in a mouse model that age of initial infection with RSV influences respiratory function in later life - infection of neonatal mice, d 7d of age, primes for a Th2 immune response that contributes to the development of long-term airways dysfunction. The mechanism(s) underlying the influence of age on the immune and pulmonary responses elicited in response to RSV infection remains obscure. Our preliminary data reveal that expression of IL-4Ra is developmentally regulated such that its expression declines on lung mDCs and Th1 cells as animals age (i.e. expression is highest in the neonate). Furthermore, downregulation of IL-4Ra expression during RSV infection in the neonate 1) inhibits the initial Th2 biased immune response and 2) protects against persistent Th2 immune deviation and pulmonary pathophysiology observed with secondary RSV infection in the adult. Our data support the expression of IL-4Ra in early life as a critical and novel age-dependent mechanism of severe RSV infection. Therefore, our hypothesis is that developmentally regulated expression of IL-4Ra on neonatal myeloid dendritic cells (mDCs) is responsible for biasing immune and pulmonary responses towards asthmatic type responses in later life. Specifically, our preliminary data suggest a unique mechanism whereby elevated levels of IL-4Ra on neonatal mDCs initiates a Th2-polarized immune response to RSV and signaling through IL-4Ra on neonatal Th1 cells results in their ablation. We will explore the validity of this hypothesis in the following specific aims: Aim 1 will determine if age-related expression of IL-4Ra on mDCs is responsible for altered mDC function in neonatal RSV infection resulting in an asthma-promoting DC. We will leverage conditional cell ablation and adoptive transfer strategies to determine the functional role of IL-4Ra on neonatal mDCs. Aim 2 will explore our prediction that elevated levels of IL-4Ra on neonatal Th1 cells are responsible for their specific ablation during neonatal RSV infection and for the persistence of the asthma phenotype following neonatal RSV infection. Aim 3 will demonstrate that exacerbation of allergic asthma in adult mice is due to an altered Th2- inducing mDC formed during neonatal RSV infection. The concepts presented here are novel; and the data derived from these studies are expected to have a positive paradigm-shifting impact in understanding RSV- mediated asthma.
描述(由申请人提供:呼吸道合胞病毒(RSV)是全球婴儿细支气管炎的主要原因,其医疗保健费用估计为每年365至5.85亿美元,每年为5.85亿美元。人类流行病学研究已确定初始感染时的年龄在以前的儿童哮喘发展中是一种独立的危险因素 - 我们以前曾在儿童哮喘中发挥作用。新生儿小鼠的年龄为7D,有助于长期气道功能障碍的Th2免疫反应的素数。 (即新生儿中的表达最高)。我们的数据支持早期IL-4RA的表达是严重的RSV感染的关键和新颖的年龄依赖性机制。因此,我们的假设是,在新生儿髓样树突状细胞(MDC)上,IL-4RA的发育调节表达是导致对以后生命中对哮喘类型反应的免疫和肺反应的偏见。具体而言,我们的初步数据提出了一种独特的机制,即新生儿MDC上的IL-4RA水平升高启动对RSV的Th2极性免疫反应,并通过Neonatal Th1细胞对IL-4RA发出信号传导导致其消融。我们将在以下特定目的中探讨该假设的有效性:AIM 1将确定IL-4RA在MDC上与年龄相关的表达是否导致新生儿RSV感染中MDC功能的改变,从而导致哮喘促进的DC。我们将利用条件细胞消融和收养转移策略来确定IL-4RA在新生儿MDC上的功能作用。 AIM 2将探讨我们的预测,即新生儿TH1细胞对新生儿RSV感染期间的特定消融水平的升高以及新生儿RSV感染后哮喘表型的持续性。 AIM 3将表明,成年小鼠过敏性哮喘的加剧是由于在新生儿RSV感染过程中形成的Th2诱导MDC所致。这里提出的概念是新颖的。预计从这些研究中得出的数据将对理解RSV介导的哮喘产生阳性范式转移影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephania A Cormier其他文献
Th2 mediated pulmonary inflammation induces the differential expression of a unique eosinophil-associated ribonuclease gene
- DOI:
10.1016/s0091-6749(02)81628-1 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Stephania A Cormier;Shubing Yuang;Dawn Dimina;Nancy A Lee;James J Lee - 通讯作者:
James J Lee
Stephania A Cormier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephania A Cormier', 18)}}的其他基金
2023 Focus Meeting of the Pacific Basin Consortium for Environment and Health
2023年太平洋盆地环境与健康联盟焦点会议
- 批准号:
10753652 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
KC Donnelly Externship - LSU SRP MATHIEU: AERMOD spatial predictive model for airborne exposure to PCBs
KC Donnelly Externship - LSU SRP MATHIEU:空气中 PCB 暴露的 AERMOD 空间预测模型
- 批准号:
10580929 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
19th International Conference of the Pacific Basin Consortium for Environment and Health
第十九届太平洋盆地环境与健康联盟国际会议
- 批准号:
10469074 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
2022 Biology of Acute Respiratory Infection GRC / GRS
2022 急性呼吸道感染生物学 GRC / GRS
- 批准号:
10388659 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
促进健康相关研究多样性的研究补充(管理补充 - 不允许进行临床试验)
- 批准号:
10400398 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
NOSI to Support Enhancement of Software Tools for Multilevel Mediation Analysis for Investigating Effects of Environmental and Individual Risk Factors on Respiratory Diseases
NOSI 支持增强多级中介分析软件工具,以调查环境和个人风险因素对呼吸道疾病的影响
- 批准号:
10403859 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
Environmental Health in a Changing Climate: the 19th International Conference of the Pacific Basin Consortium for Environment and Health
气候变化中的环境健康:第十九届太平洋盆地环境与健康联盟国际会议
- 批准号:
10307011 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
LSU Superfund Research Center - Environmentally Persistent Free Radicals
路易斯安那州立大学超级基金研究中心 - 环境持久性自由基
- 批准号:
10770302 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
LSU Superfund Research Center - Environmentally Persistent Free Radicals
路易斯安那州立大学超级基金研究中心 - 环境持久性自由基
- 批准号:
10575424 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
14th International Congress on Combustion By-Products and Their Health Effects
第十四届国际燃烧副产品及其健康影响大会
- 批准号:
8837868 - 财政年份:2014
- 资助金额:
$ 37.5万 - 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
- 批准号:82373219
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
- 批准号:32300701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
- 批准号:82302332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目